Relocated to the hospital’s former casualty area, the clinic provides a larger workspace for patient navigators to coordinate referrals, appointments and follow-up care.
The international research team found that natural killer (NK) cells in patients with mutations in the calreticulin (CALR) gene retain much of their ability to attack abnormal cells.
NICRAT provides national leadership, institutional coordination and oversight, while BioVana is responsible for technical implementation.
Talzenna (talazoparib), a PARP inhibitor, is used alongside Xtandi (enzalutamide), an androgen receptor inhibitor, to target cancer through complementary mechanisms.
A 2026 review of more than 42,000 breast cancer patients across 28 sub-Saharan African countries found that 63% were diagnosed at an advanced stage.
Abbott has integrated Oncodetect into electronic health record networks and is conducting more than 20 studies across multiple tumour types.
The initiative, running throughout Breast Cancer Awareness Month, awards one free mammogram screening for every 10,000 steps recorded through the myAster app.
The clinic brings together specialists in surgery, oncology, radiology, and reconstruction, along with nursing and patient coordination services.
The approval gives AbbVie another Parkinson’s product following its acquisition of Cerevel Therapeutics.
The designation recognises the hospitals’ specialised capabilities in breast cancer diagnosis and treatment, including multidisciplinary care, advanced technologies, clinical research and patient support.